Obstructive sleep apnoea following rapid weight gain secondary to treatment with vigabatrin (Sabril®)
- 1 June 1997
- Vol. 6 (3) , 233-235
- https://doi.org/10.1016/s1059-1311(97)80011-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Improvement of epileptic seizure control with treatment of obstructive sleep apnoeaSeizure, 1996
- Epilepsy and sleep apnea syndromeNeurology, 1994
- A Risk-Benefit Assessment of Vigabatrin in the Treatment of Neurological DisordersDrug Safety, 1994
- ACUTE EFFECTS OF OBSTRUCTIVE SLEEP APNOEABritish Journal of Anaesthesia, 1993
- Obstructive sleep apnoea.Thorax, 1993
- Obstructive Sleep Apnoea and Depression — Diagnostic and Treatment ImplicationsAustralian & New Zealand Journal of Psychiatry, 1992
- Six-year follow-up study on the efficacy and safety of vigabatrin in patients with epilepsyActa Neurologica Scandinavica, 1992
- Neck circumference and other clinical features in the diagnosis of the obstructive sleep apnoea syndrome.Thorax, 1992
- Vigabatrin and psychosis.Journal of Neurology, Neurosurgery & Psychiatry, 1991
- Evaluation of vigabatrin as an add-on drug in the management of severe epilepsy.Journal of Neurology, Neurosurgery & Psychiatry, 1990